Your browser is no longer supported. Please, upgrade your browser.
Settings
TEVA [NYSE]
Teva Pharmaceutical Industries Limited
Index- P/E- EPS (ttm)-3.64 Insider Own1.02% Shs Outstand1.10B Perf Week-6.68%
Market Cap11.62B Forward P/E3.83 EPS next Y2.77 Insider Trans-2.29% Shs Float1.09B Perf Month-15.46%
Income-3990.00M PEG- EPS next Q0.60 Inst Own52.60% Short Float2.82% Perf Quarter13.48%
Sales16.66B P/S0.70 EPS this Y-297.90% Inst Trans1.77% Short Ratio3.25 Perf Half Y7.28%
Book/sh9.16 P/B1.16 EPS next Y5.60% ROA-7.60% Target Price12.35 Perf Year-16.46%
Cash/sh1.99 P/C5.34 EPS next 5Y5.60% ROE-34.00% 52W Range6.25 - 13.56 Perf YTD9.95%
Dividend- P/FCF18.22 EPS past 5Y-32.00% ROI-9.50% 52W High-15.78% Beta1.42
Dividend %- Quick Ratio0.70 Sales past 5Y-3.30% Gross Margin46.80% 52W Low82.73% ATR0.50
Employees39717 Current Ratio1.00 Sales Q/Q11.60% Oper. Margin-21.40% RSI (14)49.45 Volatility2.96% 4.10%
OptionableYes Debt/Eq2.59 EPS Q/Q37.10% Profit Margin-24.00% Rel Volume2.11 Prev Close10.61
ShortableYes LT Debt/Eq2.27 EarningsFeb 10 BMO Payout- Avg Volume9.43M Price11.42
Recom2.80 SMA20-3.11% SMA502.07% SMA2006.19% Volume9,655,411 Change7.64%
Nov-25-20Initiated Oppenheimer Perform
Aug-06-20Upgrade Barclays Underweight → Equal Weight $10 → $13
Jul-27-20Resumed Goldman Neutral $12
Jun-01-20Upgrade SunTrust Hold → Buy
Apr-24-20Resumed Citigroup Neutral $10
Apr-06-20Upgrade UBS Neutral → Buy $14 → $12
Feb-24-20Downgrade Edward Jones Hold → Sell
Nov-12-19Upgrade JP Morgan Underweight → Neutral $8
Oct-17-19Upgrade Gabelli & Co Hold → Buy
Aug-07-19Downgrade Evercore ISI Outperform → In-line
Jul-19-19Initiated Wolfe Research Peer Perform
Jul-15-19Downgrade Morgan Stanley Equal-Weight → Underweight
Jul-10-19Resumed Credit Suisse Neutral
Jul-05-19Upgrade Argus Hold → Buy
Jun-11-19Initiated Barclays Underweight $8
Jun-03-19Upgrade Oppenheimer Perform → Outperform $12
May-30-19Downgrade BofA/Merrill Buy → Underperform
May-28-19Downgrade UBS Buy → Neutral
Mar-20-19Initiated SunTrust Hold
Mar-07-19Resumed UBS Buy $22
Feb-21-21 06:20AM  
Feb-20-21 06:30AM  
Feb-18-21 11:08AM  
07:15AM  
Feb-12-21 12:40AM  
Feb-11-21 10:25AM  
09:14AM  
Feb-10-21 06:00PM  
01:50PM  
10:19AM  
09:31AM  
09:26AM  
07:52AM  
07:48AM  
07:16AM  
07:00AM  
06:15AM  
03:41AM  
Feb-09-21 11:50AM  
Feb-08-21 11:00PM  
10:33AM  
Feb-07-21 06:36AM  
Jan-31-21 05:51AM  
Jan-26-21 05:48AM  
Jan-14-21 05:17PM  
Jan-09-21 05:51AM  
Jan-08-21 03:01PM  
Jan-07-21 04:00PM  
08:00AM  
Jan-06-21 06:06AM  
Jan-04-21 05:51AM  
Jan-02-21 05:45PM  
Dec-29-20 06:06AM  
Dec-21-20 05:27PM  
Dec-18-20 10:25AM  
Dec-17-20 06:06AM  
Dec-16-20 01:57PM  
Dec-15-20 10:55AM  
Nov-27-20 09:40AM  
02:22AM  
Nov-26-20 06:43AM  
Nov-23-20 08:52AM  
Nov-20-20 03:00PM  
11:17AM  
Nov-19-20 09:41PM  
09:52AM  
Nov-18-20 09:40PM  
09:44AM  
Nov-17-20 08:48PM  
Nov-15-20 10:55AM  
Nov-14-20 03:20PM  
10:51AM  
Nov-13-20 01:25PM  
10:29AM  
Nov-12-20 09:01PM  
07:21AM  
Nov-11-20 08:55PM  
03:55PM  
Nov-10-20 08:54PM  
03:10PM  
09:16AM  
Nov-09-20 08:53PM  
Nov-08-20 10:34AM  
03:12AM  
Nov-07-20 12:18PM  
10:14AM  
Nov-06-20 10:53AM  
Nov-05-20 11:02PM  
09:02PM  
04:17PM  
09:23AM  
08:40AM  
07:59AM  
07:00AM  
06:15AM  
Nov-04-20 08:55PM  
06:05PM  
Nov-03-20 06:15PM  
Nov-02-20 10:44PM  
08:33PM  
11:10AM  
08:45AM  
Oct-31-20 11:27PM  
10:33AM  
09:32AM  
Oct-30-20 08:40PM  
Oct-28-20 11:58PM  
09:14PM  
05:08PM  
06:06AM  
Oct-27-20 09:13PM  
01:24PM  
Oct-26-20 09:09PM  
08:15PM  
Oct-23-20 11:00PM  
05:45PM  
09:50AM  
Oct-22-20 08:19AM  
Oct-21-20 06:32PM  
02:55PM  
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system and pain area include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. The company was founded in 1901 and is headquartered in Petach Tikva, Israel.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stark David MatthewExec. VP Chief Legal OfficerFeb 16Sale11.123,92643,6692,974Feb 17 04:09 PM
Fridriksdottir HafrunExecutive VP, Global R&DFeb 16Sale11.122,09823,336103,294Feb 17 04:07 PM
Drape EricExecutive VP Global OperationsFeb 16Sale11.132,07923,13539,572Feb 17 04:06 PM
Stark David MatthewExec. VP Chief Legal OfficerFeb 09Sale12.6965,312829,1032,974Feb 11 04:12 PM
O'Grady Brendan P.EVP, North America CommercialFeb 09Sale12.6920,694262,70078,146Feb 11 04:08 PM
Nazzi GianfrancoEVP, International MarketsFeb 09Sale12.7221,635275,21760,410Feb 11 04:07 PM
Fridriksdottir HafrunExecutive VP, Global R&DFeb 09Sale12.6929,496374,437100,037Feb 11 04:05 PM
Drape EricExecutive VP Global OperationsFeb 09Sale12.7217,979228,70937,725Feb 11 04:04 PM
Dethlefs SvenEVP Global Marketing&PortfolioFeb 09Sale12.6929,657376,48159,404Feb 11 04:03 PM
Daniell RichardExec. VP, European CommercialFeb 09Sale12.7268,422870,38910,765Feb 11 04:02 PM
Daniell RichardExec. VP, European CommercialSep 09Sale8.983332,99210,765Sep 10 09:04 AM
Crane Rosemary ADirectorAug 11Sale11.902,86034,03833,509Aug 13 04:07 PM
Griffin Deborah AChief Accounting OfficerMar 17Sale7.169446,7620Mar 19 08:09 AM
Stark David MatthewExec. VP Chief Legal OfficerMar 17Sale7.162,35916,8992,974Mar 19 07:38 AM
O'Grady Brendan P.EVP, North America CommercialMar 17Sale7.164703,36714,868Mar 19 07:37 AM
Nazzi GianfrancoEVP, International MarketsMar 17Sale7.173452,47419,844Mar 19 07:36 AM
Fridriksdottir HafrunExecutive VP, Global R&DMar 17Sale7.165143,68245,561Mar 19 07:33 AM
Daniell RichardExec. VP, European CommercialMar 17Sale7.176164,41810,400Mar 19 07:31 AM
Griffin Deborah AChief Accounting OfficerMar 04Sale11.234,80753,9800Mar 05 08:16 AM
O'Grady Brendan P.EVP, North America CommercialMar 03Sale11.374635,26214,159Mar 05 08:13 AM
Nazzi GianfrancoEVP, International MarketsMar 03Sale11.775486,44819,315Mar 05 08:11 AM
Daniell RichardExec. VP, European CommercialMar 03Sale11.7799111,6609,719Mar 05 08:07 AM
Griffin Deborah AChief Accounting OfficerMar 03Sale11.371,16613,2530Mar 04 06:39 AM
Griffin Deborah AChief Accounting OfficerMar 02Sale11.602,94134,1120Mar 04 06:39 AM